Fidelity Investments’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-584
| Closed | -$20K | – | 4473 |
|
|
2020
Q3 | $20K | Sell |
584
-2,305,625
| -100% | -$49.1M | ﹤0.01% | 3060 |
|
|
2020
Q2 | $38.5M | Sell |
2,306,209
-249,722
| -10% | -$4.24M | ﹤0.01% | 1274 |
|
|
2020
Q1 | $36.9M | Sell |
2,555,931
-320,352
| -11% | -$8.19M | 0.01% | 1146 |
|
|
2019
Q4 | $96.3M | Buy |
2,876,283
+463,698
| +19% | +$13M | 0.01% | 926 |
|
|
2019
Q3 | $50.5M | Buy |
2,412,585
+1,003
| +0% | +$20.5K | 0.01% | 1160 |
|
|
2019
Q2 | $50.2M | Sell |
2,411,582
-323,001
| -12% | -$6.65M | 0.01% | 1214 |
|
|
2019
Q1 | $61.1M | Buy |
2,734,583
+635,362
| +30% | +$15M | 0.01% | 1128 |
|
|
2018
Q4 | $50.2M | Sell |
2,099,221
-11,260
| -0.5% | -$291K | 0.01% | 1139 |
|
|
2018
Q3 | $57.6M | Sell |
2,110,481
-413,890
| -16% | -$11.7M | 0.01% | 1195 |
|
|
2018
Q2 | $67.9M | Sell |
2,524,371
-288,900
| -10% | -$8.84M | 0.01% | 1134 |
|
|
2018
Q1 | $89.5M | Buy |
2,813,271
+243,231
| +9% | +$8.56M | 0.01% | 1033 |
|
|
2017
Q4 | $97.2M | Sell |
2,570,040
-378,845
| -13% | -$12.2M | 0.01% | 1007 |
|
|
2017
Q3 | $73.1M | Sell |
2,948,885
-67,171
| -2% | -$1.45M | 0.01% | 1120 |
|
|
2017
Q2 | $62M | Sell |
3,016,056
-479,103
| -14% | -$9.14M | 0.01% | 1198 |
|
|
2017
Q1 | $75.9M | Sell |
3,495,159
-1,453,868
| -29% | -$29.8M | 0.01% | 1104 |
|
|
2016
Q4 | $101M | Buy |
4,949,027
+37,200
| +0.8% | +$760K | 0.01% | 987 |
|
|
2016
Q3 | $73.7M | Buy |
4,911,827
+35,260
| +0.7% | +$476K | 0.01% | 1128 |
|
|
2016
Q2 | $52.8M | Sell |
4,876,567
-280,410
| -5% | -$3.81M | 0.01% | 1252 |
|
|
2016
Q1 | $69.9M | Sell |
5,156,977
-1,180,437
| -19% | -$18.4M | 0.01% | 1117 |
|
|
2015
Q4 | $117M | Buy |
6,337,414
+250,179
| +4% | +$4.63M | 0.02% | 896 |
|
|
2015
Q3 | $154M | Buy |
+6,087,235
| New | +$142M | 0.02% | 760 |
|
Fidelity Investments's AIMT Position: Q4 2020 in Review
Fidelity Investments sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 584 shares — an estimated $20K sold.
Fidelity Investments first reported a position in AIMT in Q3 2015 and held it in 21 quarters. The position peaked at $154M in Q3 2015. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.
- Fidelity Investments reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
- Fidelity Investments sold 584 Aimmune Therapeutics shares in Q4 2020, an estimated $20K.
- Fidelity Investments first reported a position in Aimmune Therapeutics in Q3 2015 and held it in 21 quarters.
- Fidelity Investments's Aimmune Therapeutics position peaked at $154M in Q3 2015.
- 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.
Based on Fidelity Investments's 13F filing for Q4 2020, filed 8 Feb 2021.